Amanta Healthcare
add_icon

Amanta Healthcare

197.75
-4.03
(-2.00%)
Market Cap
767.85 Cr
PE Ratio
53.58
Volume
19,137.00
Day High - Low
197.75 - 197.75
52W High-Low
209.95 - 92.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
767.85 Cr
EPS
4.33
PE Ratio
53.58
PB Ratio
3.57
Book Value
56.71
EBITDA
63.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
6.75
Debt to Equity
1.33
Forecast For
Actual

Company News

View All News
Caret
positive
Amanta Healthcare starts ops at new Steriport facilitySep 02, 2026
Amanta Healthcare has commenced manufacturing at its new Steriport facility located at its Kheda campus, marking a significant operational milestone for the company.
neutral
Amanta Healthcare Limited has scheduled its 31st Annual General Meeting for September 16, 2026. The meeting will be held via video conference, with remote e-voting available from September 13 to 15. Shareholders can access the annual report online.
neutral
Amanta Healthcare reports ₹331.05 lakh net profit for Q1FY26, down 5.6% YoY. Revenue rises 5.4% to ₹6,880.32 lakh. AGM scheduled for Sep 16, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,840.00
#1 4,41,477.63
36.91
#1 61,673.90
12.69
#1 11,565
26.53
34.00
9,322.00
2,47,469.81
85.36
11,067.00
13.95
2,568
65.50
63.65
4,965.50
1,88,871.66
86.95
13,886.20
20.34
2,138
3.28
52.16
1,119.10
1,12,607.65
24.28
27,657.90
17.64
5,026
-34.90
45.64
1,366.00
1,10,351.67
33.22
29,044.60
2.24
3,870
-39.18
35.27
1,969.00
1,06,297.76
95.94
6,867.80
22.01
890
#1 123.93
68.28
1,165.50
97,280.68
29.91
35,058.60
3.90
4,158
-69.10
47.72
1,679.80
96,651.98
25.88
34,145.20
5.56
3,503
25.21
57.04
2,095.00
95,790.22
#1 17.09
29,038.90
#1 26.75
5,356
16.00
28.17
2,280.00
94,163.08
44.87
14,636.40
14.85
1,938
29.13
37.57
Growth Rate
Revenue Growth
5.40 %
Net Income Growth
41.90 %
Cash Flow Change
3.93 %
ROE
-38.02 %
ROCE
-37.21 %
EBITDA Margin (Avg.)
-1.76 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
187
172
227
263
282
276
291
294
Expenses
147
133
173
206
223
215
228
234
EBITDA
40
39
54
56
59
61
63
60
Operating Profit %
20 %
22 %
23 %
20 %
21 %
22 %
21 %
20 %
Depreciation
17
17
17
18
20
18
19
19
Interest
38
40
49
35
34
28
21
21
Profit Before Tax
-15
-18
62
3
5
15
21
21
Tax
4
4
7
5
2
4
6
7
Net Profit
-19
-22
55
-2
4
11
15
15
EPS in ₹
-7.04
-8.14
20.54
-0.79
1.35
3.71
4.33
4.20

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
388
392
392
374
352
382
558
Fixed Assets
244
242
240
232
228
217
207
Current Assets
105
131
136
131
118
138
239
Capital Work in Progress
0
0
0
9
0
7
82
Investments
0
2
3
0
4
8
7
Other Assets
144
149
149
133
120
150
262
Total Equity & Liabilities
388
392
392
374
352
382
558
Current Liabilities
73
123
106
97
102
115
141
Non Current Liabilities
285
262
214
214
184
170
197
Total Equity
29
7
72
63
66
96
220
Reserve & Surplus
2
-20
36
36
40
68
181
Share Capital
27
27
37
27
27
29
39

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-8
-0
6
-6
1
-1
81
Investing Activities
-9
-13
-6
-7
-10
-25
-94
Operating Activities
38
31
62
43
58
47
49
Financing Activities
-37
-18
-50
-42
-46
-24
126

Share Holding

% Holding
Sept 2024
Feb 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
85.52 %
85.52 %
63.56 %
85.60 %
63.56 %
63.56 %
63.72 %
63.80 %
FIIs
0.00 %
0.00 %
2.21 %
0.00 %
1.00 %
1.10 %
0.85 %
0.43 %
DIIs
0.00 %
0.00 %
12.22 %
0.00 %
11.34 %
11.24 %
12.88 %
12.92 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
20.28 %
0.00 %
17.35 %
16.91 %
16.00 %
17.45 %
Others
14.48 %
14.48 %
1.74 %
14.40 %
6.75 %
7.19 %
6.56 %
5.39 %
No of Share Holders
192
200
30,695
361
360
16,181
15,222
12,612

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Sept 2026 170.05 198.50
26 Sept 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Sept 2025 140.05 139.35
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 122.15 120.16
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 104.95 106.15
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2026 137.70 124.40
05 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Aug 2026 159.00 170.05

Announcements

Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 03, 2026
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Amanta Healthcare Limited Announces Commissioning Of New Steriport LineSep 02, 2026
Intimation - Regulation 36(1)(B) Of The SEBI Listing RegulationsAug 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 25, 2026
Annual Report For Financial Year 2025-26Aug 24, 2026
Notice Of 31St Annual General Meeting And Annual Report For F.Y. 2025-26Aug 24, 2026
Reg. 34 (1) Annual Report.Aug 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 08, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 05, 2026
Statement Of Deviation Or Variation In Utilization Of Funds If Any Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")Aug 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 05, 2026
To Approve Unaudited Financial Results For The Quarter Ended 30Th June 2026Aug 05, 2026
Board Meeting Outcome for To Approval Unaudited Financial Results For Quarter Ended 30Th June 2026Aug 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 03, 2026
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended June 30 2026Jul 29, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 01, 2026
Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 - Off-Market Transfer Of Equity SharesJul 01, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 29, 2026
Closure of Trading WindowJun 27, 2026
Intimation Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Jun 22, 2026
Intimation Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Jun 18, 2026
Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 (The Insider Trading Regulations) Open-Market Sale Of Equity SharesJun 17, 2026
Intimation For Commissioning Of Solar Power Plant For Captive ConsumptionMay 30, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
Statement Of Deviation Or Variation In Utilization Of Funds If AnyMay 29, 2026
Statement Of Deviation Or Variation In Utilization Of Funds If Any.May 29, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 19, 2026
Revision In Remuneration Of Managing Director - Recommended By Board Of DirectorsMay 19, 2026
Change In AuditorsMay 19, 2026
Press ReleaseMay 19, 2026
Investor PresentationMay 19, 2026
Amendment To The CodeMay 19, 2026
Financial Results For FY 2025-26May 19, 2026
Board Meeting Outcome for Audited Financial Results For FY 2025-26May 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 16, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31 2026May 11, 2026
Clarification Letter On Earlier Disclosure Submitted On April 18Th 2026 Pursuant To SEBI (PIT) Regulations 2015Apr 22, 2026
Clarification On Earlier Disclosure Submitted On April 1St 2026Apr 18, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Small Cap Fund Direct-Growth
0.11%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
60.03
ATR(14)
Less Volatile
5.40
STOCH(9,6)
Neutral
78.48
STOCH RSI(14)
Neutral
41.28
MACD(12,26)
Bullish
0.52
ADX(14)
Strong Trend
29.05
UO(9)
Bearish
56.08
ROC(12)
Uptrend And Accelerating
3.52
WillR(14)
Neutral
-46.07